291 related articles for article (PubMed ID: 6416726)
1. Demonstration of mycobacterial antigens in nerve biopsies from leprosy patients using peroxidase-antiperoxidase immunoenzyme technique.
Mshana RN; Humber DP; Harboe M; Belehu A
Clin Immunol Immunopathol; 1983 Dec; 29(3):359-68. PubMed ID: 6416726
[TBL] [Abstract][Full Text] [Related]
2. Demonstration of Mycobacterium leprae antigen in nerves of tuberculoid leprosy.
Barros U; Shetty VP; Antia NH
Acta Neuropathol; 1987; 73(4):387-92. PubMed ID: 2441563
[TBL] [Abstract][Full Text] [Related]
3. Immunohistological localization of mycobacterial antigens within the peripheral nerves of treated leprosy patients and their significance to nerve damage in leprosy.
Shetty VP; Uplekar MW; Antia NH
Acta Neuropathol; 1994; 88(4):300-6. PubMed ID: 7839822
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of mycobacterial antigens in leprosy tissues.
Mshana RN; Belehu A; Stoner GL; Harboe M; Haregewoin A
Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):1-10. PubMed ID: 7042609
[TBL] [Abstract][Full Text] [Related]
5. In situ demonstration of Mycobacterium leprae antigens in leprosy lesions using monoclonal antibodies.
Narayanan RB; Girdhar BK; Malaviya GN; Sengupta U
Immunol Lett; 1990 Jun; 24(3):179-83. PubMed ID: 2200752
[TBL] [Abstract][Full Text] [Related]
6. Class-specific immunoglobulins and antibodies to mycobacterial sonicates and autoantigens in leprosy patients and contacts.
Mathew JM; Muthukkaruppan V
Microb Pathog; 1993 Nov; 15(5):367-76. PubMed ID: 8015417
[TBL] [Abstract][Full Text] [Related]
7. Immunologically reactive M. leprae antigens with relevance to diagnosis and vaccine development.
Sampaio LH; Stefani MM; Oliveira RM; Sousa AL; Ireton GC; Reed SG; Duthie MS
BMC Infect Dis; 2011 Jan; 11():26. PubMed ID: 21269435
[TBL] [Abstract][Full Text] [Related]
8. Demonstration of Mycobacterium leprae specific antigens in leprosy lesions using monoclonal antibodies.
Narayanan RB; Ramu G; Sinha S; Sengupta U; Malaviya GN; Desikan KV
Indian J Lepr; 1985; 57(2):258-64. PubMed ID: 2416852
[TBL] [Abstract][Full Text] [Related]
9. Transcription factors STAT-4, STAT-6 and CREB regulate Th1/Th2 response in leprosy patients: effect of M. leprae antigens.
Upadhyay R; Dua B; Sharma B; Natrajan M; Jain AK; Kithiganahalli Narayanaswamy B; Joshi B
BMC Infect Dis; 2019 Jan; 19(1):52. PubMed ID: 30642265
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
[TBL] [Abstract][Full Text] [Related]
11. The detection of Mycobacterium leprae protein and carbohydrate antigens in skin and nerve from leprosy patients with type 1 (reversal) reactions.
Lockwood DN; Colston MJ; Khanolkar-Young SR
Am J Trop Med Hyg; 2002 Apr; 66(4):409-15. PubMed ID: 12164297
[TBL] [Abstract][Full Text] [Related]
12. Reciprocity between Regulatory T Cells and Th17 Cells: Relevance to Polarized Immunity in Leprosy.
Sadhu S; Khaitan BK; Joshi B; Sengupta U; Nautiyal AK; Mitra DK
PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004338. PubMed ID: 26751584
[TBL] [Abstract][Full Text] [Related]
13. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
Reitan LJ; Closs O; Belehu A
Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
[TBL] [Abstract][Full Text] [Related]
14. Reversal of T cell anergy in leprosy patients: in vitro presentation with Mycobacterium leprae antigens using murabutide and Trat peptide in liposomal delivery.
Sridevi K; Khanna N; Chattree V; Pal PC; Haq W; Rao DN
Int Immunopharmacol; 2003 Nov; 3(12):1589-600. PubMed ID: 14555284
[TBL] [Abstract][Full Text] [Related]
15. Antigens of Mycobacterium leprae identified by immunoprecipitation with sera from leprosy and tuberculosis patients.
Britton WJ; Hellqvist L; Garsia RJ; Basten A
Clin Exp Immunol; 1988 Mar; 71(3):394-8. PubMed ID: 3289801
[TBL] [Abstract][Full Text] [Related]
16. Immunohistological studies of skin biopsies from patients with lepromatous leprosy.
Mshana RN; Humber DP; Belehu A; Harboe M
J Clin Immunol; 1983 Jan; 3(1):22-9. PubMed ID: 6338025
[TBL] [Abstract][Full Text] [Related]
17. T cell responses to fractionated Mycobacterium leprae antigens in leprosy. The lepromatous nonresponder defect can be overcome in vitro by stimulation with fractionated M. leprae components.
Ottenhoff TH; Converse PJ; Gebre N; Wondimu A; Ehrenberg JP; Kiessling R
Eur J Immunol; 1989 Apr; 19(4):707-13. PubMed ID: 2659369
[TBL] [Abstract][Full Text] [Related]
18. Cellular immune response to Mycobacterium leprae infection in human immunodeficiency virus-infected individuals.
Sampaio EP; Caneshi JR; Nery JA; Duppre NC; Pereira GM; Vieira LM; Moreira AL; Kaplan G; Sarno EN
Infect Immun; 1995 May; 63(5):1848-54. PubMed ID: 7729894
[TBL] [Abstract][Full Text] [Related]
19. Potential role of B7-1 and CD28 molecules in immunosuppression in leprosy.
Agrewala JN; Kumar B; Vohra H
Clin Exp Immunol; 1998 Jan; 111(1):56-63. PubMed ID: 9472661
[TBL] [Abstract][Full Text] [Related]
20. Events surrounding the recognition of Mycobacterium leprae in nerves.
Ridley MJ; Waters MF; Ridley DS
Int J Lepr Other Mycobact Dis; 1987 Mar; 55(1):99-108. PubMed ID: 3549942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
